Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Glycobiology

• Publication date

  2010-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/glycob/cwq020PMID 20181792PMCID PMC2900896
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques

  2009cited by this paper
• Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target

  2009cited by this paper
• Human Immunodeficiency Virus type 1 elite neutralizers

  2009cited by this paper
• Unusual Molecular Architecture of the Machupo Virus Attachment Glycoprotein

  2009cited by this paper
• Proposal for a standard system for drawing structural diagrams of N‐ and O‐linked carbohydrates and related compounds

  2009influential reference
• Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm

  2009cited by this paper
• A Human Embryonic Kidney 293T Cell Line Mutated at the Golgi α-Mannosidase II Locus

  2009cited by this paper
• Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers

  2009cited by this paper
• A Glycoconjugate Antigen Based on the Recognition Motif of a Broadly Neutralizing Human Immunodeficiency Virus Antibody, 2G12, Is Immunogenic but Elicits Antibodies Unable To Bind to the Self Glycans of gp120

  2008cited by this paper
• Structural and quantitative analysis of N-linked glycans by matrix-assisted laser desorption ionization and negative ion nanospray mass spectrometry.

  2008influential reference
• The therapeutic phase I trial of the recombinant native HIV-1 Tat protein

  2008cited by this paper
• Crystal Structure and Carbohydrate Analysis of Nipah Virus Attachment Glycoprotein: a Template for Antiviral and Vaccine Design

  2008cited by this paper
• An Engineered Saccharomyces cerevisiae Strain Binds the Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody 2G12 and Elicits Mannose-Specific gp120-Binding Antibodies

  2008influential reference
• Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody.

  2007cited by this paper
• Glycoprotein Structural Genomics: Solving the Glycosylation Problem

  2007cited by this paper
• Exploiting the defensive sugars of HIV-1 for drug and vaccine design

  2007cited by this paper
• Ligands for the β-Glucan Receptor, Dectin-1, Assigned Using “Designer” Microarrays of Oligosaccharide Probes (Neoglycolipids) Generated from Glucan Polysaccharides*

  2006cited by this paper
• A time- and cost-efficient system for high-level protein production in mammalian cells.

  2006cited by this paper
• Inhibition of hybrid- and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway.

  2006cited by this paper
• Neutralizing Antibody Responses against Autologous and Heterologous Viruses in Acute versus Chronic Human Immunodeficiency Virus (HIV) Infection: Evidence for a Constraint on the Ability of HIV To Completely Evade Neutralizing Antibody Responses

  2006cited by this paper
• GP120: target for neutralizing HIV-1 antibodies.

  2006cited by this paper
• Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection.

  2005cited by this paper
• Fragmentation of negative ions from carbohydrates: Part 2. Fragmentation of high-mannose N-linked glycans

  2005cited by this paper
• Fragmentation of negative ions from carbohydrates: Part 1. Use of nitrate and other anionic adducts for the production of negative ion electrospray spectra from N-linked carbohydrates

  2005cited by this paper
• Fragmentation of negative ions from carbohydrates: Part 3. Fragmentation of hybrid and complex N-linked glycans

  2005cited by this paper
• Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12.

  2005influential reference
• Antibody vs. HIV in a clash of evolutionary titans.

  2005cited by this paper
• The immunobiology of Guillain‐Barré syndromes

  2005cited by this paper
• Structural determination of N‐linked glycans by matrix‐assisted laser desorption/ionization and electrospray ionization mass spectrometry

  2005cited by this paper
• HIV vaccine design and the neutralizing antibody problem

  2004cited by this paper
• Printed covalent glycan array for ligand profiling of diverse glycan binding proteins.

  2004cited by this paper
• Reactivity-based one-pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody.

  2004cited by this paper
• Toward fully synthetic carbohydrate-based HIV antigen design: on the critical role of bivalency.

  2004cited by this paper
• Characterization of glycopeptides from HIV-ISF2 gp120 by liquid chromatography mass spectrometry

  2004cited by this paper
• Antibody neutralization and escape by HIV-1

  2003cited by this paper
• Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition

  2003influential reference
• The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of α1→2 Mannose Residues on the Outer Face of gp120

  2002influential reference
• Antibodies, viruses and vaccines

  2002cited by this paper
• Oligosaccharide microarrays for high-throughput detection and specificity assignments of carbohydrate-protein interactions

  2002cited by this paper
• The Mannose-Dependent Epitope for Neutralizing Antibody 2G12 on Human Immunodeficiency Virus Type 1 Glycoprotein gp120

  2002influential reference
• Conformational studies of oligosaccharides and glycopeptides: complementarity of NMR, X-ray crystallography, and molecular modelling.

  2002cited by this paper
• Structure and function in rhodopsin: High-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line

  2002cited by this paper
• Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

  2000cited by this paper
• Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells.

  2000cited by this paper
• The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.

  1999cited by this paper
• A statistical analysis of N- and O-glycan linkage conformations from crystallographic data.

  1999cited by this paper
• The high degree of internal flexibility observed for an oligomannose oligosaccharide does not alter the overall topology of the molecule.

  1998cited by this paper
• Sequencing of N-linked oligosaccharides directly from protein gels: in-gel deglycosylation followed by matrix-assisted laser desorption/ionization mass spectrometry and normal-phase high-performance liquid chromatography.

  1997cited by this paper
• Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".

  1997cited by this paper
• Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design.

  1997cited by this paper
• Adjuvant properties of aluminum and calcium compounds.

  1995cited by this paper
• Ion exchange and purification of carbohydrates on a Nafion® membrane as a new sample pretreatment for matrix‐assisted laser desorption/ionization mass spectrometry

  1995cited by this paper
• The human immunodeficiency virus.

  1991cited by this paper
• Antibodies against defined carbohydrate structures of Candida albicans protect H9 cells against infection with human immunodeficiency virus-1 in vitro.

  1991cited by this paper
• Recognition of human immunodeficiency virus glycoproteins by natural anti-carbohydrate antibodies in human serum.

  1991cited by this paper
• Glycosylation of the envelope glycoprotein from a polytropic murine retrovirus in two different host cells.

  1990cited by this paper
• Isolation, characterization, and properties of Saccharomyces cerevisiae mnn mutants with nonconditional protein glycosylation defects.

  1990cited by this paper
• Human immunodeficiency virus.

  1990cited by this paper
• A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates

  1988cited by this paper

• Serum antibody screening using glycan arrays.

  2024cites this paper
• A quinolin-8-ol sub-millimolar inhibitor of UGGT, the ER glycoprotein folding quality control checkpoint

  2022cites this paper
• Synthesis and Immunological Evaluation of Pentamannose-Based HIV-1 Vaccine Candidates.

  2022cites this paper
• Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans

  2022cites this paper
• Glycans in HIV-1 vaccine design - engaging the shield.

  2022cites this paper
• Differential recognition of oligomannose isomers by glycan-binding proteins involved in innate and adaptive immunity

  2021cites this paper
• Formation and fragmentation of doubly and triply charged ions in the negative ion spectra of neutral N-glycans from viral and other glycoproteins

  2021cites this paper
• Glycans in Virus-Host Interactions: A Structural Perspective

  2021cites this paper
• Negative ion mass spectrometry for the analysis of N-linked glycans.

  2020cites this paper
• Serum alpha-mannosidase as an additional barrier to eliciting oligomannose-specific HIV-1-neutralizing antibodies

  2020cites this paper
• Networks of HIV-1 Envelope Glycans Maintain Antibody Epitopes in the Face of Glycan Additions and Deletions

  2020cites this paper
• Glycan microarray: Toward drug discovery and development

  2020cites this paper
• Protein and Glycan Mimicry in HIV Vaccine Design

  2019cites this paper
• Antibody responses to the HIV-1 envelope high mannose patch.

  2019influential citation
• Toward Automated Enzymatic Synthesis of Oligosaccharides.

  2018cites this paper
• Signature of Antibody Domain Exchange by Native Mass Spectrometry and Collision-Induced Unfolding.

  2018cites this paper
• Structural principles controlling HIV envelope glycosylation.

  2017cites this paper
• Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates.

  2017cites this paper
• Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses

  2017cites this paper
• Emerging Principles for the Therapeutic Exploitation of

  2016cites this paper
• HIV-1 glycan density drives the persistence of the mannose patch within an infected 1 individual 2 3

  2016cites this paper
• HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual

  2016cites this paper
• How to assess the binding strength of antibodies elicited by vaccination against HIV and other viruses

  2016cites this paper
• Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies

  2015cites this paper
• Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers.

  2015cites this paper
• Molecular basis of sugar recognition by collectin-K1 and the effects of mutations associated with 3MC syndrome

  2015cites this paper
• Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design.

  2015cites this paper
• Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans.

  2015cites this paper
• Ion Mobility Mass Spectrometry for Ion Recovery and Clean-Up of MS and MS/MS Spectra Obtained from Low Abundance Viral Samples

  2015cites this paper
• Modulation of glycan recognition by clustered saccharide patches.

  2014cites this paper
• Molecular Recognition of HIV Glycans by Antibodies

  2014cites this paper
• HIV glycans in infection and immunity

  2014cites this paper
• Glycan microarrays: Powerful tools for biomarker discovery

  2014cites this paper
• Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike.

  2014influential citation
• Uukuniemi Phlebovirus Assembly and Secretion Leave a Functional Imprint on the Virion Glycome

  2014cites this paper
• Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2009–2010

  2014influential citation
• Emerging Principles for the Therapeutic Exploitation of Glycosylation

  2014cites this paper
• Anti-Carbohydrate HIV Vaccine Design

  2014cites this paper
• Solution NMR Analyses of the C-type Carbohydrate Recognition Domain of DC-SIGNR Protein Reveal Different Binding Modes for HIV-derived Oligosaccharides and Smaller Glycan Fragments

  2013cites this paper
• Carbohydrate microarrays.

  2013cites this paper
• Pharmacokinetics and pharmacodynamics in HIV prevention; current status and future directions: a summary of the DAIDS and BMGF sponsored think tank on pharmacokinetics (PK)/pharmacodynamics (PD) in HIV prevention.

  2013cites this paper
• High-Throughput Profiling of Anti-Glycan Humoral Responses to SIV Vaccination and Challenge

  2013cites this paper
• Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120

  2013cites this paper
• Antibodies expose multiple weaknesses in the glycan shield of HIV

  2013cites this paper
• Recent advances on the use of structural biology for the design of novel envelope immunogens of HIV-1.

  2013cites this paper
• Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain.

  2013cites this paper
• Advances in HIV-1 Assembly and Release

  2013cites this paper
• Synthesis of Functional and Variable HIV-1 Envelope Glycoproteins

  2013cites this paper
• Conference report: "Functional Glycomics in HIV Type 1 Vaccine Design" workshop report, Bethesda, Maryland, April 30-May 1, 2012.

  2013cites this paper
• Solution NMR Analyses of the C-type Carbohydrate Recognition Domain of DC-SIGNR Reveal Different Binding Modes for HIV-derived Oligosaccharides and Smaller Glycan Fragments

  2013cites this paper
• The Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of HIV Type-1

  2012cites this paper
• The design and development of an HIV-1 vaccine to elicit a broadly neutralising antibody response

  2012cites this paper
• Solubility of carbohydrates in heavy water.

  2012cites this paper
• MALDI-MS/MS with Traveling Wave Ion Mobility for the Structural Analysis of N-Linked Glycans

  2012cites this paper
• Occluding the Mannose Moieties on Human Immunodeficiency Virus Type 1 gp120 with Griffithsin Improves the Antibody Responses to Both Proteins in Mice

  2012cites this paper
• Structural insights into key sites of vulnerability on HIV‐1 Env and influenza HA

  2012cites this paper
• 2G12-Expressing B Cell Lines May Aid in HIV Carbohydrate Vaccine Design Strategies

  2012cites this paper
• STD NMR Study of the Interactions between Antibody 2G12 and Synthetic Oligomannosides that Mimic Selected Branches of gp120 Glycans

  2012cites this paper
• Antigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine Design.

  2012cites this paper
• How Can HIV-Type-1-Env Immunogenicity Be Improved to Facilitate Antibody-Based Vaccine Development?

  2012cites this paper
• Neoglycolipid-based oligosaccharide microarray system: preparation of NGLs and their noncovalent immobilization on nitrocellulose-coated glass slides for microarray analyses.

  2012cites this paper
• A bacterial lipooligosaccharide that naturally mimics the epitope of the HIV-neutralizing antibody 2G12 as a template for vaccine design.

  2012cites this paper
• Structural basis for germline gene usage of a potent class of antibodies targeting the CD4 binding site of HIV-1 gp120

  2012cites this paper
• The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade

  2011cites this paper
• Auf dem Weg zur automatisierten Oligosaccharid‐ Synthese

  2011cites this paper
• Toward automated oligosaccharide synthesis.

  2011cites this paper
• Bacterial, fungal, and algal lectins: combatants in tug of war against HIV.

  2011cites this paper
• A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

  2011cites this paper
• Glycan microarrays for decoding the glycome.

  2011cites this paper
• Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12.

  2011cites this paper
• High-Mannose Glycan-Dependent Epitopes Are Frequently Targeted in Broad Neutralizing Antibody Responses during Human Immunodeficiency Virus Type 1 Infection

  2011cites this paper
• Ion Mobility Mass Spectrometry for Extracting Spectra of N-Glycans Directly from Incubation Mixtures Following Glycan Release: Application to Glycans from Engineered Glycoforms of Intact, Folded HIV gp120

  2011cites this paper
• Yeast-Elicited Cross-Reactive Antibodies to HIV Env Glycans Efficiently Neutralize Virions Expressing Exclusively High-Mannose N-Linked Glycans

  2010cites this paper
• Antibody epitope exposure and neutralization of HIV-1.

  2010cites this paper
• Antibody 2G12 Recognizes Di-Mannose Equivalently in Domain- and Nondomain-Exchanged Forms but Only Binds the HIV-1 Glycan Shield if Domain Exchanged

  2010cites this paper
• Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens

  2010influential citation
• The Antiretroviral Lectin Cyanovirin-N Targets Well-Known and Novel Targets on the Surface of Entamoeba histolytica Trophozoites

  2010cites this paper